HaemoPREF: Further evaluation of patient perception and preference for treatment in a real world setting-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

HaemoPREF: Further evaluation of patient perception and preference for treatment in a real world setting

Published:2017-09-19 Issue:6 Volume:23 Page:884-893
ISSN:1351-8216
Container-title:Haemophilia
language:en
Short-container-title:Haemophilia

Author:

Bonanad S.¹^ORCID,Schulz M.²,Gordo A.³,Spurden D.⁴^ORCID,Cicchetti M.⁵,Cappelleri J. C.⁶,Tolley C.⁷^ORCID,Staunton H.⁷,Brohan E.⁷^ORCID

Affiliation:

1. Haematology Department; Hospital Universitari i Politècnic La Fe; Valencia Spain

2. Pfizer Pharma GmbH; Berlin Germany

3. Lab.Pfizer, Lda; Porto Salvo Portugal

4. Pfizer Ltd; Surrey UK

5. A Parexel Company; Execupharm; Groton CT USA

6. Global Product Development; Pfizer Inc; Groton CT USA

7. Adelphi Values; Bollington Cheshire UK

Funder

Pfizer

Publisher

Wiley

Subject

Genetics(clinical),Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/hae.13321/fullpdf

Reference34 articles.

1. World Federation for Hemophilia Guidelines for the management of haemophilia www1.wfh.org/publications/files/pdf-1472.pdf

2. On-demand vs. prophylactic treatment for severe haemophilia in Norway and Sweden: differences in treatment characteristics and outcome;Steen Carlsson;Haemophilia,2003

3. Assessment of the impact of treatment on quality of life of patients with haemophilia A at different ages: insights from two clinical trials on turoctocog alfa;Santagostino;Haemophilia,2014

4. A randomized comparison of two prophylaxis regimens and a paired comparison of on-demand and prophylaxis treatments in hemophilia A management;Valentino;J Thromb Haemost,2012

5. The benefits of prophylaxis: views of adolescents with severe haemophilia;Khair;Haemophilia,2012

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hereditary factor X deficiency in America survey: impact on quality of life and burden of disease in patients and caregivers;Blood Coagulation & Fibrinolysis;2024-02-21

2. Patient preferences for gene therapy in haemophilia: Results from the PAVING threshold technique survey;Haemophilia;2021-09

3. Patient Preferences to Assess Value IN Gene Therapies: Protocol Development for the PAVING Study in Hemophilia;Frontiers in Medicine;2021-03-09

4. Development and testing of the Satisfaction Questionnaire with Intravenous or Subcutaneous Hemophilia Injection and results from the Phase 3 HAVEN 3 study of emicizumab prophylaxis in persons with haemophilia A without FVIII inhibitors;Haemophilia;2021-01-28

5. Patient perspectives regarding gene therapy in haemophilia: Interviews from the PAVING study;Haemophilia;2020-11-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3